Irbesartan

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

89 Suppliers, 39 USDMF, 28 CEP/COS, 14 JDMF, 23 EU WC, 31 KDMF, 14 NDC API, 42 Listed Suppliers

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

16 Suppliers

16 Suppliers

DOSSIERs // Finished Dosage Forms

885 Dossiers, 115 FDA Orange Book, 502 Europe, 59 Canada, 63 Australia, 32 South Africa, 114 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 150MG, TABLET;ORAL - 300MG, TABLET;ORAL - 75MG, TABLET;ORAL - 12.5MG;150MG, TABLET;ORAL - 12.5MG;300MG, TABLET;ORAL - 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 27 BASF, 20 Roquette, 17 SPI Pharma, 16 Microlex e.U, 14 Seppic, 12 Sigachi Industries, 12 Gangwal Chemicals, 12 Gangwal Healthcare, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 10 Nanjing Well Pharmaceutical, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 DFE Pharma, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 Prachin Chemical, 5 Actylis, 5 Ingredion Pharma Solutions, 5 Vasa Pharmachem, 4 Pharmatrans-Sanaq, 3 Clariant, 3 Boai NKY Pharmaceuticals Ltd, 3 Kima Chemical, 3 Jai Radhe Sales, 2 DKSH, 2 Nanjing Bold Chemical, 2 Seqens, 2 Finar, 2 Nomisma Healthcare, 2 Ulanqab Kema New Material, 2 The Dow Chemical Company, 1 Avesta Pharma, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Aeon Procare, 1 ACG Worldwide, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Qualicaps, 1 Shanghai Welltone Material Technology Co., Ltd, 1 NEWEDGE Overseas, 1 Rochem International Inc, 1 Chynops Pharma, 1 Pfanstiehl, 1 Alcedo Pharmachem, 1 Minakem

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 42 Direct Compression, 35 Disintegrants & Superdisintegrants, 32 Controlled & Modified Release, 29 Lubricants & Glidants, 27 Granulation, 27 Solubilizers, 26 Thickeners and Stabilizers, 22 Parenteral, 21 Topical, 17 Co-Processed Excipients, 17 Taste Masking, 17 Chewable & Orodispersible Aids, 15 Film Formers & Plasticizers, 8 API Stability Enhancers, 8 Emulsifying Agents, 6 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents

GLOBAL SALES INFORMATION

28 US Medicaid Prescriptions, 385 Finished Drug Prices

MARKET PLACE

11 APIs, 5 DOSSIERS // FDF

PATENTS

6 Health Canada Patents

6 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 2 EDQM Standards, 1 USP Standards, 3 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 94 News

Information, Expiry & Status of Health Canada Patents covering Irbesartan.

Irbesartan

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

89 Suppliers

39 USDMF

28 CEP/COS

14 JDMF

23 EU WC

31 KDMF

14 NDC API

42 Listed Suppliers

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

16 Suppliers

DOSSIERs // Finished Dosage Forms

885 Dossiers

115 FDA Orange Book

502 Europe

59 Canada

63 Australia

32 South Africa

114 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 150MG

TABLET;ORAL - 300MG

TABLET;ORAL - 75MG

TABLET;ORAL - 12.5MG;150MG

TABLET;ORAL - 12.5MG;300MG

TABLET;ORAL - 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

39 Kerry

27 BASF

20 Roquette

17 SPI Pharma

16 Microlex e.U

14 Seppic

12 Sigachi Industries

12 Gangwal Chemicals

12 Gangwal Healthcare

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 Corel Pharma Chem

10 Nanjing Well Pharmaceutical

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 DFE Pharma

7 Ideal Cures Pvt Ltd

6 Lonza Capsugel

6 Prachin Chemical

5 Actylis

5 Ingredion Pharma Solutions

5 Vasa Pharmachem

4 Pharmatrans-Sanaq

3 Clariant

3 Boai NKY Pharmaceuticals Ltd

3 Kima Chemical

3 Jai Radhe Sales

2 DKSH

2 Nanjing Bold Chemical

2 Seqens

2 Finar

2 Nomisma Healthcare

2 Ulanqab Kema New Material

2 The Dow Chemical Company

1 Avesta Pharma

1 Qianhao Chemical (Hebei) Co., Ltd

1 Aeon Procare

1 ACG Worldwide

1 Shijiazhuang Huaxu Pharmaceutical

1 Qualicaps

1 Shanghai Welltone Material Technology Co., Ltd

1 NEWEDGE Overseas

1 Rochem International Inc

TABLET;ORAL - 12.5MG;75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 25MG;300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons